PREDICTOM is inviting general practitioners to take part in our survey. With the aim of identifying current clinical guidelines and practice for screening, identifying and diagnosing Alzheimer's Disease and early dementia, we want to hear your views.
Photo: Svein Lunde, Helse Stavanger
Published 10 February 2025
Share this article
We are inviting general practitioners to complete this short survey. It should take around 10 minutes to complete. We want to hear about your current clinical practice when managing patients who you suspect have dementia. We also ask some questions about Alzheimer’s disease and mild cognitive impairment.
Your responses will help us develop recommendations for optimising clinical practice guidelines, considering new technologies to support diagnosis and facilitators and barriers to implementation in primary care settings.
PREDICTOM has unveiled a standardized MRI protocol designed to identify early biomarkers of Alzheimer’s disease. With dementia cases in the EU projected to double by 2050, early detection is more critical than ever.
A new study from the European research project PREDICTOM shows that even small memory problems can be linked to early changes in the brain, changes that can be measured with a simple brain scan.